Clinical Trial Update: AI-ECG Accessory Pathway Localisation Study

View source ↗

Summary

An Imperial College London trial aims to localize accessory pathways using AI-enabled ECG; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wolff-parkinson-white Syndrome

Snippet

Sponsor: Imperial College London | Conditions: Accessory Pathway, Artifical Intelligence | Status: NOT_YET_RECRUITING